These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23169297)

  • 21. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
    Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulated Krüppel‑like factor 4 expression is associated with the aggressiveness of prostate cancer.
    Zhang N; Su P; Li X; Xi J; Li X; Xu L
    Oncol Rep; 2019 Mar; 41(3):1789-1796. PubMed ID: 30747213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-19 Promotes Cell Proliferation, Invasion, Migration, and EMT by Inhibiting SPRED2-mediated Autophagy in Osteosarcoma Cells.
    Xie C; Liu S; Wu B; Zhao Y; Chen B; Guo J; Qiu S; Cao YM
    Cell Transplant; 2020; 29():963689720962460. PubMed ID: 33023313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
    Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
    Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deregulation of FOXO3A during prostate cancer progression.
    Shukla S; Shukla M; Maclennan GT; Fu P; Gupta S
    Int J Oncol; 2009 Jun; 34(6):1613-20. PubMed ID: 19424579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy.
    Wang Q; Stamp GW; Powell S; Abel P; Laniado M; Mahony C; Lalani EN; Waxman J
    J Clin Pathol; 1999 Jan; 52(1):29-34. PubMed ID: 10343609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
    Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
    BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
    Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
    Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
    Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
    Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism.
    Ma XN; Liu XY; Yang YF; Xiao FJ; Li QF; Yan J; Zhang QW; Wang LS; Li XY; Wang H
    Biochem Biophys Res Commun; 2011 Jul; 410(4):803-8. PubMed ID: 21703232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of T cell immunoglobulin mucin-3 in prostate cancer.
    Piao YR; Piao LZ; Zhu LH; Jin ZH; Dong XZ
    Asian Pac J Cancer Prev; 2013; 14(6):3897-901. PubMed ID: 23886204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
    Singh S; Singh R; Singh UP; Rai SN; Novakovic KR; Chung LW; Didier PJ; Grizzle WE; Lillard JW
    Int J Cancer; 2009 Nov; 125(10):2288-95. PubMed ID: 19610059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
    Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
    Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score.
    Guan M; Chen Y
    J Clin Pathol; 2005 Nov; 58(11):1175-9. PubMed ID: 16254107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.
    Reis ST; Antunes AA; Pontes-Junior J; Sousa-Canavez JM; Dall'Oglio MF; Piantino CB; Cruz JA; Morais DR; Srougi M; Leite KR
    Int Braz J Urol; 2012; 38(2):167-74. PubMed ID: 22555040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of drs mRNA in human prostate carcinomas.
    Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H
    Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.